Virpax Pharmaceuticals, Inc(NASDAQ:VRPX) 
Virpax Pharmaceuticals, Inc. develops and manufactures non-opioid and non-addictive based drug compounds and drug delivery systems for pain management. It offers products, such as Probudur, an injectable bupivacaine hydrogel for postoperative pain management; Epoladerm, a diclofenac metered-dose spr...
Website: http://www.virpaxpharma.com
Founded: 2016
CEO: Anthony P. Mack
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-02-18
P
O 7.50
H 8.25
L 7.00
C 7.75
V 7,180,794
10EMA 7.75
20EMA 7.75
60EMA 7.75
120EMA 7.75
250EMA 7.75